Head and neck cancer therapeutics market to reach $4.2b by 2030

An ageing population is driving demand for advanced therapeutics.

The global market for head and neck cancer therapeutics is projected to hit $4.2b by 2030 at a compound annual growth rate of 7.1$, said Research and Markets.

The sector’s expansion is attributed to rising cases of head and neck cancers worldwide, increased awareness of early detection, and developments in treatments such as immunotherapy and targeted therapies.

In line with this, an ageing population is driving the demand for advanced therapeutics due to their vulnerability to cancer.

Moreover, increased investment in research, government efforts, and collaborations between pharmaceutical companies and research institutions are accelerating the development of new treatment options.